Results 191 to 200 of about 27,181 (240)

The impact of two-year community-wide pharmacy interventions on the public's knowledge, attitudes, beliefs and behaviors about pharmacists as immunizers. [PDF]

BMC Public Health
Halperin DM, Castri AMD, Isenor JE, Lowe WK, Ye L, Kervin MS, Whittle CA, Halperin SA, Improve ACCESS Team for the Canadian Immunization Research Network (CIRN).   +8 more
europepmc   +1 more source

Estimating the impact of decreasing vaccination response times for outbreaks of vaccine-preventable diseases in low- and middle-income countries. [PDF]

BMC Glob Public Health
Delport D, Muellenmeister AM, Greig J, Abeysuriya RG, Scott N.   +4 more
europepmc   +1 more source

Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention. [PDF]

Hum Vaccin Immunother
Andani A, Abbing-Karahagopian V, Kavaliauskaite J, Schaffner TO, Sohn WY, Graña MG, Marshall H, Martinon-Torres F, Bonanni P, Rappuoli R, Taha MK.   +10 more
europepmc   +1 more source

Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study. [PDF]

Hum Vaccin Immunother
Villagomez-Martinez S, Kharit S, Galustyan A, Zambrano B, Singh Dhingra M, B'Chir S, Syrkina O, Lyabis O, Rehm C.   +8 more
europepmc   +1 more source

Sustained salivary IgG but short-lived IgA responses following primary and booster MenACWY-TT vaccination in older adults. [PDF]

Hum Vaccin Immunother
Visser M, van Rooijen DM, Wolf J, Beckers L, de Jonge MI, Buisman A, den Hartog G.   +6 more
europepmc   +1 more source

Invasive Meningococcal Disease in the Post-COVID-19 Era in South America. [PDF]

Vaccines (Basel)
Sáfadi MAP, Falconi JF, Abalos MG, Serra L, Gentile A, Diaz A, Cortes CP, Villena R.   +7 more
europepmc   +1 more source

Spatial analysis of meningococcal c vaccination coverage in children in BRAZIL between 2012 and 2024. [PDF]

BMC Pediatr
Pereira PLG, Rodrigues GJC, Ferraz ML, Souza MD, da Silva TPR, Matozinhos FP.   +5 more
europepmc   +1 more source

Gonococcal Vaccine Development: Lessons from Group B Meningococcal Vaccines. [PDF]

EBioMedicine, 2017
europepmc   +1 more source

Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential. [PDF]

PLoS Med
Gottlieb SL, Rees H, Peters RPH.
europepmc   +1 more source